Cargando…
Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338149/ https://www.ncbi.nlm.nih.gov/pubmed/35810248 http://dx.doi.org/10.1007/s10549-022-06671-8 |
| _version_ | 1784759905907900416 |
|---|---|
| author | Davey, Matthew G. Kerin, Michael J. |
| author_facet | Davey, Matthew G. Kerin, Michael J. |
| author_sort | Davey, Matthew G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9338149 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93381492022-07-31 Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer Davey, Matthew G. Kerin, Michael J. Breast Cancer Res Treat Letter to the Editor Springer US 2022-07-10 2022 /pmc/articles/PMC9338149/ /pubmed/35810248 http://dx.doi.org/10.1007/s10549-022-06671-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Davey, Matthew G. Kerin, Michael J. Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer |
| title | Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer |
| title_full | Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer |
| title_fullStr | Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer |
| title_full_unstemmed | Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer |
| title_short | Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer |
| title_sort | using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338149/ https://www.ncbi.nlm.nih.gov/pubmed/35810248 http://dx.doi.org/10.1007/s10549-022-06671-8 |
| work_keys_str_mv | AT daveymatthewg usingmenopausestatusand21geneexpressionassaytoinformchemotherapybenefitinnodepositivebreastcancer AT kerinmichaelj usingmenopausestatusand21geneexpressionassaytoinformchemotherapybenefitinnodepositivebreastcancer |